InsidersTradesSigma
Browse the detailed record of transactions filed by Martin Jönsson, Chairman & CEO. Director active across 4 companies, notably AlzeCure Pharma AB. Cumulatively, 3 disclosures have been published. History available since 25 August 2025. The latest transaction was disclosed on 6 March 2026 (Purchase). Regulator: FIN-FSA. All data is openly available.
3 of 3 declarations
Martin Jönsson is the CEO of AlzeCure Pharma AB. He leads the company in developing new therapies for neurodegenerative diseases. With a strong background in the pharmaceutical sector, he is committed to advancing research projects and strengthening AlzeCure's market position. Under his leadership, the company has focused on innovation and collaboration with other industry players.